The Investigation of Haplotype Phasing Efficiency at the PAH Gene Region in Iranian Family Trios

The Investigation of Haplotype Phasing Efficiency at the PAH Gene Region in Iranian Family Trios

Show other versions (1)

Background: The haplotype phasing is more useful than genotyping markers independently at carrier detection and prenatal diagnosis of diseases. The PAH gene region contains several markers used in detection of PKU disease. In the present study, the efficiency of BglII-EcoRI-VNTR haplotype phasing i...

Full description

Bibliographic Details
Main Authors:	Z Fazeli, S Vallian
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2009-12-01
Series:	Iranian Journal of Public Health
Subjects:	Phenylalanine hydroxylase (PAH) Phenylketonuria (PKU) Haplotype
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/3163

Similar Items

The Investigation of Haplotype Phasing Efficiency at the PAH Gene Region in Iranian Family Trios
by: Z Fazeli, et al.
Published: (2009-12-01)

Genetic Diversity and Balancing Selection within the Human Phenylalanine Hydroxylase (PAH) Gene Region in Iranian Population
by: J Mowla, et al.
Published: (2012-04-01)

Genetic Diversity and Balancing Selection within the Human Phenylalanine Hydroxylase (PAH) Gene Region in Iranian Population
by: A Haghighatnia, et al.
Published: (2012-05-01)

PAH mutation spectrum and correlation with PKU manifestation in north Jiangsu province population
by: Zhen-Wen Wang, et al.
Published: (2018-02-01)

The complete European guidelines on phenylketonuria: diagnosis and treatment
by: A. M. J. van Wegberg, et al.
Published: (2017-10-01)

Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China
by: Ning Liu, et al.
Published: (2017-10-01)

Identification of a Novel Mutation in the PAH Gene in an Iranian Phenylketonuria Family: A Case Report
by: Masoumeh RAZIPOUR, et al.
Published: (2017-04-01)

Mutations in the PAH gene: A Tool for population genetics study
by: Stojiljković Maja, et al.
Published: (2007-01-01)

NUTRITIONAL KNOWLEDGE IN PHENYLKETONURIA (PKU)
by: Beatriz D. O. MIRANDA DA CRUZ, et al.
Published: (2009-07-01)

PAH and QDPR deficiency associated mutations in the Novosibirsk region of the Russian Federation: Correlation of mutation type with disease manifestation and severity
by: Baturina Olga A., et al.
Published: (2014-01-01)

Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase
by: Júlio César Rocha, et al.
Published: (2021-09-01)

Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance
by: M. Kreile, et al.
Published: (2020-12-01)

Incidence of Phenylketonuria in Southern Iran
by: Asadollah Habib, et al.
Published: (2010-06-01)

Phenylketonuria (PKU): A problem solved?
by: Christine S. Brown, et al.
Published: (2016-03-01)

Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report
by: Fran Rohr, et al.
Published: (2020-03-01)

Association between minihaplotypes and mutations at the phenylalanine hydroxylase locus in Latvian phenylketonuria patients
by: Proņina Natālija, et al.
Published: (2011-01-01)

Prevention of maternal phenylketonuria. Dietary management in the preconception period and during pregnancy
by: Joanna Żółkowska, et al.
Published: (2018-03-01)

Investigation of five common mutations on Phenylalanine Hydroxylase Gene of Phenylketonuria Patients from Two Provinces in North of Iran
by: Daniel Zamanfar, et al.
Published: (2017-01-01)

Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial
by: Roman Trepp, et al.
Published: (2020-02-01)

Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence
by: Benjamin Green, et al.
Published: (2019-10-01)

Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians’ current practices
by: Nataliya Yuskiv, et al.
Published: (2019-01-01)

Analysis of EX5del4232ins268 and EX5del955 PAH gene mutations in Ukrainian patients with phenylketonuria
by: Volodymyr Pampukha, et al.
Published: (2017-06-01)

Trastornos neurológicos a consecuencia de la mutación del gen que codifica para fenilalanina hidroxilas
by: Alvear-Sedán Ciro, et al.
Published: (2013-12-01)

Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China
by: Yong-An Zhou, et al.
Published: (2012-01-01)

Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the phenylalanine in human plasma
by: Hossein Danafar, et al.
Published: (2015-09-01)

First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU
by: Alicia de la Parra, et al.
Published: (2017-12-01)

Phenylketonuria Diagnosis by Massive Parallel Sequencing and Genotype-Phenotype Association in Brazilian Patients
by: Rafael Hencke Tresbach, et al.
Published: (2021-12-01)

Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe
by: Tracy Brock Lowe, et al.
Published: (2020-09-01)

Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study
by: Nicola Longo, et al.
Published: (2018-07-01)

Molecular diagnosis of phenylketonuria: From defective protein to disease-causing gene mutation
by: Pavlović Sonja, et al.
Published: (2009-01-01)

Uniformity of Food Protein Interpretation Amongst Dietitians for Patients with Phenylketonuria (PKU): 2020 UK National Consensus Statements
by: Sharon Evans, et al.
Published: (2020-07-01)

by: Tasmina Hydery, et al.
Published: (2019-06-01)

Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU
by: British Inherited Metabolic Diseases Group (BIMDG) Dietitians Group, et al.
Published: (2019-01-01)

Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers
by: Ana Maria Martins, et al.
Published: (2020-09-01)

Strategies to engage lost to follow-up patients with phenylketonuria in the United States: Best practice recommendations
by: Jennifer Beazer, et al.
Published: (2020-06-01)

Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia
by: Fernando Andrade, et al.
Published: (2021-08-01)

An Efficient Trio-Based Mini-Haplotyping Method for Genetic Diagnosis of Phenylketonuria
by: Saeed Talebi, et al.
Published: (2016-07-01)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
by: Priscila Nicolao Mazzola, et al.
Published: (2015-12-01)

Spectrum of Phenylalanine Hydroxylase Gene Mutations in Hamadan and Lorestan Provinces of Iran and Their Associations with Variable Number of Tandem Repeat Alleles
by: Reza Alibakhshi, et al.
Published: (2018-05-01)

Quantitative analysis by flow cytometry of green fluorescent protein-tagged human phenylalanine hydroxylase expressed in Dictyostelium
by: Kim Hye-Lim, et al.
Published: (2017-12-01)